# OXAZEPAM
> **ANDA218261** · Abbreviated New Drug Application (Generic) · Sponsor: LEADING · Approved 2025-03-03
## Drug
- **FDA Application Number:** ANDA218261
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXAZEPAM
- **Generic name:** OXAZEPAM
- **Active ingredients:** OXAZEPAM
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LEADING
- **Manufacturer:** Leading Pharma, LLC
- **First approval:** 2025-03-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218261)
---
*AI Analytics · CC0 1.0*